Aspen Aerogels' (ASPN) "Sell (D)" Rating Reiterated at Weiss Ratings

Key Points

• Aspen Aerogels' stock rating has been reiterated as a "sell (D)" by Weiss Ratings, indicating ongoing concerns about the company's performance.
• Recent trading activity shows ASPN shares at $8.31, with estimates suggesting a Moderate Buy consensus and an average price target of $19.50.
• In the latest quarterly earnings, Aspen Aerogels reported a revenue of $78.02 million, beating analyst expectations, but showed a significant 33.8% revenue decline year-over-year.

Aspen Aerogels (NYSE:ASPN - Get Free Report)'s stock had its "sell (d)" rating reiterated by equities researchers at Weiss Ratings in a research note issued on Wednesday,Weiss Ratings reports.

ASPN has been the topic of several other reports. Barclays lowered Aspen Aerogels from an "equal weight" rating to an "underweight" rating and increased their target price for the stock from $7.00 to $16.00 in a report on Monday, August 11th. Canaccord Genuity Group reduced their target price on Aspen Aerogels from $11.00 to $10.00 and set a "buy" rating on the stock in a report on Friday, August 8th. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, two have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, Aspen Aerogels currently has a consensus rating of "Moderate Buy" and an average price target of $19.50.

Aspen Aerogels Stock Performance

Shares of ASPN stock traded up $0.25 during trading on Wednesday, reaching $8.31. 1,970,762 shares of the company's stock were exchanged, compared to its average volume of 1,965,599. The company has a quick ratio of 3.31, a current ratio of 3.98 and a debt-to-equity ratio of 0.34. The firm's fifty day moving average price is $7.13 and its 200-day moving average price is $6.46. Aspen Aerogels has a twelve month low of $4.16 and a twelve month high of $26.90. The stock has a market capitalization of $684.41 million, a PE ratio of -2.18 and a beta of 2.80.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The construction company reported ($0.04) EPS for the quarter, beating analysts' consensus estimates of ($0.12) by $0.08. Aspen Aerogels had a positive return on equity of 2.92% and a negative net margin of 78.53%.The firm had revenue of $78.02 million for the quarter, compared to analyst estimates of $72.53 million. During the same period in the prior year, the firm posted $0.21 EPS. The company's revenue for the quarter was down 33.8% on a year-over-year basis. Aspen Aerogels has set its FY 2025 guidance at -3.860--3.730 EPS. As a group, sell-side analysts anticipate that Aspen Aerogels will post 0.17 EPS for the current year.

Insider Buying and Selling

In other Aspen Aerogels news, CAO Santhosh P. Daniel sold 4,410 shares of the stock in a transaction dated Tuesday, August 12th. The stock was sold at an average price of $7.31, for a total value of $32,237.10. Following the completion of the transaction, the chief accounting officer directly owned 19,879 shares in the company, valued at approximately $145,315.49. This trade represents a 18.16% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 3.40% of the company's stock.

Hedge Funds Weigh In On Aspen Aerogels

Several large investors have recently bought and sold shares of ASPN. Nisa Investment Advisors LLC raised its position in Aspen Aerogels by 1,094.8% in the second quarter. Nisa Investment Advisors LLC now owns 4,791 shares of the construction company's stock valued at $28,000 after purchasing an additional 4,390 shares during the last quarter. SBI Securities Co. Ltd. raised its position in shares of Aspen Aerogels by 67.3% during the second quarter. SBI Securities Co. Ltd. now owns 6,343 shares of the construction company's stock worth $38,000 after acquiring an additional 2,551 shares during the last quarter. Tower Research Capital LLC TRC raised its position in shares of Aspen Aerogels by 184.6% during the second quarter. Tower Research Capital LLC TRC now owns 7,235 shares of the construction company's stock worth $43,000 after acquiring an additional 4,693 shares during the last quarter. Acadian Asset Management LLC bought a new position in shares of Aspen Aerogels during the first quarter worth about $43,000. Finally, Banque Cantonale Vaudoise bought a new position in shares of Aspen Aerogels during the first quarter worth about $45,000. 97.64% of the stock is currently owned by institutional investors.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.